"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2019/0048346 A1,048-657-403-142-790,2019-02-14,2019,US 201816169606 A,2018-10-24,US 201816169606 A;;US 201615122381 A;;US 2015/0020012 W;;US 201461952063 P,2014-03-12,COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA,"The invention relates to compositions, methods and kits for using Argonaute-2 (Ago-2) as a systemic carrier to deliver a miRNA to an endothelial cell. The invention also relates to compositions, methods and kits for inhibiting angiogenesis and/or treating a condition by using Ago-2 as a systemic carrier to deliver a miRNA to an endothelial cell. The condition includes but is not limited to brain vascular diseases and brain tumors.",NEONC TECH INC,HOFMAN FLORENCE M;;FERREIRA RAQUEL M S;;GIANNOTTA STEVEN L;;CHEN THOMAS C,,https://lens.org/048-657-403-142-790,Patent Application,yes,0,0,4,4,8,C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;C12Y301/26;;C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;A61K45/06;;C12N15/113;;C12Y301/26,C12N15/113;;A61K31/713;;A61K38/46;;A61K45/06;;C12N15/11,,0,0,,,,DISCONTINUED
2,WO,A1,WO 2015/138636 A1,100-973-670-522-294,2015-09-17,2015,US 2015/0020012 W,2015-03-11,US 201461952063 P,2014-03-12,COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA,"The invention relates to compositions, methods and kits for using Argonaute-2 (Ago-2) as a systemic carrier to deliver a miRNA to an endothelial cell. The invention also relates to compositions, methods and kits for inhibiting angiogenesis and/or treating a condition by using Ago-2 as a systemic carrier to deliver a miRNA to an endothelial cell. The condition includes but is not limited to brain vascular diseases and brain tumors.",UNIV SOUTHERN CALIFORNIA,HOFMAN FLORENCE M;;FERREIRA RAQUEL M S;;GIANNOTTA STEVEN L;;CHEN THOMAS C,,https://lens.org/100-973-670-522-294,Patent Application,yes,5,5,4,4,8,C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;C12Y301/26;;C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;A61K45/06;;C12N15/113;;C12Y301/26,C12P19/34;;A61K48/00,,1,1,047-094-145-711-678,10.1016/j.jconrel.2013.09.015;;24075926;;pmc3891846,"ZHANG, Y. ET AL.: ""Progress In microRNA Delivery."", JOUMAL OF CONTROLLED RELEASE., vol. 172, no. 3, 25 September 2013 (2013-09-25), pages 962 - 974, XP028797338, ISSN: 0168-3659",PENDING
3,US,A1,US 2019/0367918 A1,160-856-839-136-078,2019-12-05,2019,US 201916432532 A,2019-06-05,US 201916432532 A;;US 201816169606 A;;US 201615122381 A;;US 2015/0020012 W;;US 201461952063 P,2014-03-12,COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA,"The invention relates to compositions, methods and kits for using Argonaute-2 (Ago-2) as a systemic carrier to deliver a miRNA to an endothelial cell. The invention also relates to compositions, methods and kits for inhibiting angiogenesis and/or treating a condition by using Ago-2 as a systemic carrier to deliver a miRNA to an endothelial cell. The condition includes but is not limited to brain vascular diseases and brain tumors.",NEONC TECH INC,HOFMAN FLORENCE M;;FERREIRA RAQUEL M S;;GIANNOTTA STEVEN L;;CHEN THOMAS C,,https://lens.org/160-856-839-136-078,Patent Application,yes,0,0,4,4,8,C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;C12Y301/26;;C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;A61K45/06;;C12N15/113;;C12Y301/26,C12N15/113;;A61K31/713;;A61K38/46;;A61K45/06;;C12N15/11,,0,0,,,,DISCONTINUED
4,US,A1,US 2016/0369272 A1,067-937-980-938-647,2016-12-22,2016,US 201515122381 A,2015-03-11,US 201515122381 A;;US 201461952063 P;;US 2015/0020012 W,2014-03-12,COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA,"The invention relates to compositions, methods and kits for using Argonaute-2 (Ago-2) as a systemic carrier to deliver a miRNA to an endothelial cell. The invention also relates to compositions, methods and kits for inhibiting angiogenesis and/or treating a condition by using Ago-2 as a systemic carrier to deliver a miRNA to an endothelial cell. The condition includes but is not limited to brain vascular diseases and brain tumors.",UNIV SOUTHERN CALIFORNIA,HOFMAN FLORENCE M;;FERREIRA RAQUEL M S;;GIANNOTTA STEVEN L;;CHEN THOMAS C,CHEN THOMAS (2018-10-29);;HOFMAN FLORENCE (2018-10-29);;UNIVERSITY OF SOUTHERN CALIFORNIA (2016-11-30),https://lens.org/067-937-980-938-647,Patent Application,yes,1,1,4,4,8,C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;C12Y301/26;;C12N15/111;;C12N2310/141;;C12N2320/32;;A61K31/713;;A61K38/465;;A61K45/06;;C12N15/113;;C12Y301/26,C12N15/113;;A61K31/713;;A61K38/46;;A61K45/06,,0,0,,,,DISCONTINUED
